- FTC Puts Conditions on Endo Health Solutions’ Acquisition of Boca Life Science Holdings ( )
- Statement of FTC Chairwoman Edith Ramirez on the U.S. District Court in the District of Idaho Ruling in the Matter of the Federal Trade Commission and the State of Idaho v. St. Luke’s Health System Ltd. and Saltzer Medical Group, P.A. ( )
- FTC Staff: Massachusetts Should Consider Removing Physician Supervision Requirements for Nurse Practitioners and Nurse Anesthetists ( )
- FTC Requires Community Health Systems, Inc. to Divest Two Hospitals as a Condition of Acquiring Rival Hospital Operator ( )
- Accretive Health Settles FTC Charges That It Failed to Adequately Protect Consumers’ Personal Information ( )
- FTC Approves Final Order Settling Charges That Mylan, Inc.’s Acquisition of Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. Was Anticompetitive ( )
- FTC Approves Final Order Settling Charges that Actavis, Inc.’s Acquisition of Warner Chilcott plc Would Be Anticompetitive in Four Current and Future Drug Markets ( )
- FTC Staff Submits Comment to the Commission on Dental Accreditation Regarding its Proposed Standards for Dental Therapy Education Programs ( )
- FTC Announces Agenda for Workshop Examining Competition Issues Surrounding Biologic and Follow-on Biologic Medicines: Biosimilars and Interchangeables ( )
- FTC to Host Spring Seminars on Emerging Consumer Privacy Issues ( )
- FTC Chairwoman Ramirez Testifies Before House Judiciary Subcommittee on Agency’s Enforcement of U.S. Antitrust Laws to Promote Competition and Protect Consumers ( )
- FTC to Host Workshop on the Competitive Impacts of State Regulations and Naming Conventions Concerning Follow-on Biologics ( )
- FTC Finalizes Amendments to the Premerger Notification Rules Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical Industry ( )
- FTC Charges HCG Marketer with Deceptive Advertising ( )
- FTC Extends the Deadlines for Public Comments on 13 Matters Before the Agency ( )
- FTC Settles Charges That Actavis’s Proposed $8.5 Billion Acquisition of Warner Chilcott Would be Anticompetitive ( )
- FTC Puts Conditions on Mylan’s Proposed Acquisition of Agila from Strides ( )
- FTC Sends Refund Checks to Consumers Who Bought Walgreens' 'Wal-Born' Dietary Supplements ( )
- FTC to Host Roundtable on Consumer Protection and the New Healthcare Marketplaces ( )
- FTC Cracks Down On Bogus Medical Discount Scam Targeting Seniors ( )
- FTC Sends Refund Checks to Consumers Who Bought Dietary Supplements ( )
- FTC Files Complaint Against LabMD for Failing to Protect Consumers' Privacy ( )
- FTC to Host Roundtable on Consumer Protection and the New Healthcare Marketplaces ( )
- Hospital Authority and Phoebe Putney Health System Settle FTC Charges That Acquisition of Palmyra Park Hospital Violated U.S. Antitrust Laws ( )
- FTC Sends Refunds to Consumers Who Purchased Disney- or Marvel Hero-themed Children's Vitamins ( )
- FTC: Recent Supreme Court Decision Puts Agency in Stronger Position to Protect Consumers From Anticompetitive Pay-for-Delay Drug Settlements ( )
- Marketers of Unproven Bed Bug and Head Lice Treatments Settle FTC Charges ( )
- Statement of FTC Chairwoman Edith Ramirez on the U.S. Supreme Court's Decision in FTC v. Actavis, Inc. ( )
- Hospital Authority and Phoebe Putney Defendants Agree to Court Order Barring Them from Further Integration of Hospitals Pending Administrative Trial ( )
- FTC Approves Final Order Settling Charges that Bosley, Inc., Illegally Exchanged Competitively Sensitive Business Information With Hair Club ( )